首页> 外国专利> COMPOSITIONS AND METHODS FOR DIAGNOSING LYME DISEASE AND PREDICTING ELIMINATION OF LYME DISEASE-CAUSING SPIROCHETES AFTER TREATMENT

COMPOSITIONS AND METHODS FOR DIAGNOSING LYME DISEASE AND PREDICTING ELIMINATION OF LYME DISEASE-CAUSING SPIROCHETES AFTER TREATMENT

机译:用于诊断莱姆疾病的组合物和方法,并预测治疗后血液疾病引起的螺旋体

摘要

FIELD: medicine.;SUBSTANCE: group of inventions relates to the diagnosis and prognosis of Lyme disease. The composition for the diagnosis or prognosis of Lyme disease contains 5 isolated FlaB peptides with Borrelia T-cell epitopes having amino acid sequences SEQ ID NO: 1-5; 13 isolated DbpB peptides with a Borrelia T-cell epitope having the amino acid sequence SEQ ID NO:6-18; 13 isolated peptides p66 with a T-cell epitope of Borrelia having amino acid sequences SEQ ID NO:19-31; 2 isolated OspC peptides with a Borrelia T-cell epitope having the amino acid sequences SEQ ID NO:32-33. Also disclosed is a method for detecting Lyme disease in a subject, a composition containing a set of nucleic acids encoding peptides, a set of nucleic acid-based vectors for host cell transformation, and a host cell for the expression of nucleic acids. ;EFFECT: improved diagnostic and prognostic assessment of Lyme disease. ;43 cl, 1 dwg, 7 tbl, 1 ex
机译:田地:医学。物质:发明组涉及莱姆病的诊断和预后。莱姆病的诊断或预后的组合物含有5分离的韧皮肽,具有氨基酸序列SEQ ID NO:1-5的副蛋白酶表位; 13分离的DBPB肽与博罗纹T细胞表位具有氨基酸序列SEQ ID NO:6-18; 13分离的肽p66与博洛里亚的T细胞表位,具有氨基酸序列SEQ ID NO:19-31; 2孤立的OSPC肽与博罗纹T细胞表位,具有氨基酸序列SEQ ID NO:32-33。还公开了一种用于检测受试者中莱姆疾病的方法,含有一组核酸编码肽的组合物,一组用于宿主细胞转化的核酸基载体,以及用于表达核酸的宿主细胞。 ;效果:改善莱姆病的诊断和预后评估。 ; 43 cl,1 dwg,7 tbl,1 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号